Ipca Labs

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE571A01038
  • NSEID: IPCALAB
  • BSEID: 524494
INR
1,527.80
-18 (-1.16%)
BSENSE

Mar 20

BSE+NSE Vol: 2.07 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
2,392.50
2,556.50
2,308.85
2,246.69
2,245.37
2,354.90
2,092.63
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,392.50
2,556.50
2,308.85
2,246.69
2,245.37
2,354.90
2,092.63
Raw Material Cost
564.44
569.87
617.10
660.07
482.44
588.99
545.32
Purchase of Finished goods
129.83
126.83
126.74
86.98
188.29
153.83
118.68
(Increase) / Decrease In Stocks
-36.37
84.94
-52.28
-38.76
-2.52
15.74
-20.51
Employee Cost
546.09
537.94
543.17
500.84
485.44
509.84
487.87
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
655.16
692.00
657.70
608.70
628.64
645.02
568.55
Total Expenditure (Excl Depreciation)
1,859.15
2,011.58
1,892.43
1,817.83
1,782.29
1,913.42
1,699.91
Operating Profit (PBDIT) excl Other Income
533.35
544.92
416.42
428.86
463.08
441.48
392.72
Other Income
20.19
27.86
32.66
25.82
20.11
26.26
20.61
Operating Profit (PBDIT)
553.54
572.78
449.08
454.68
483.19
467.74
413.33
Interest
17.62
19.61
18.51
21.51
16.81
22.56
24.05
Exceptional Items
17.65
-58.26
0.00
-205.05
0.00
0.00
0.00
Gross Profit (PBDT)
553.57
494.91
430.57
228.12
466.38
445.18
389.28
Depreciation
107.59
103.33
100.06
100.12
98.46
100.35
98.89
Profit Before Tax
445.98
391.58
330.51
128.00
367.92
344.83
290.39
Tax
81.93
108.08
96.09
62.22
90.59
99.39
91.41
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
364.05
283.50
234.42
65.78
277.33
245.44
198.98
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
364.05
283.50
234.42
65.78
277.33
245.44
198.98
Share in Profit of Associates
-0.38
-2.97
-1.53
-1.79
-0.97
0.31
0.16
Minority Interest
37.40
-2.04
-0.32
-3.83
28.22
16.27
6.90
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
326.27
282.57
233.21
67.82
248.14
229.48
192.24
Equity Capital
25.37
25.37
25.37
25.37
25.37
25.37
25.37
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
12.86
11.14
9.19
2.67
9.78
9.05
7.58
Diluted Earnings per share
12.86
11.14
9.19
2.67
9.78
9.05
7.58
Operating Profit Margin (Excl OI)
22.29%
21.32%
18.04%
19.09%
20.62%
18.75%
18.77%
Gross Profit Margin
23.14%
19.36%
18.65%
10.15%
20.77%
18.9%
18.6%
PAT Margin
15.22%
11.09%
10.15%
2.93%
12.35%
10.42%
9.51%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2025 is -6.42% vs 10.73% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is 15.47% vs 21.17% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is -2.12% vs 30.86% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Dec 2025 is -10.15% vs 5.94% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

Compare Quarterly Results Of Ipca Labs With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
2,392.50
1,041.26
1,351.24
129.77%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,392.50
1,041.26
1,351.24
129.77%
Raw Material Cost
564.44
79.90
484.54
606.43%
Purchase of Finished goods
129.83
217.27
-87.44
-40.24%
(Increase) / Decrease In Stocks
-36.37
66.65
-103.02
-154.57%
Employee Cost
546.09
151.88
394.21
259.55%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
655.16
154.22
500.94
324.82%
Total Expenditure (Excl Depreciation)
1,859.15
669.92
1,189.23
177.52%
Operating Profit (PBDIT) excl Other Income
533.35
371.34
162.01
43.63%
Other Income
20.19
32.12
-11.93
-37.14%
Operating Profit (PBDIT)
553.54
403.46
150.08
37.20%
Interest
17.62
1.19
16.43
1,380.67%
Exceptional Items
17.65
17.98
-0.33
-1.84%
Gross Profit (PBDT)
553.57
420.25
133.32
31.72%
Depreciation
107.59
20.32
87.27
429.48%
Profit Before Tax
445.98
399.93
46.05
11.51%
Tax
81.93
104.31
-22.38
-21.46%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
364.05
295.62
68.43
23.15%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
364.05
295.62
68.43
23.15%
Share in Profit of Associates
-0.38
0.00
-0.38
Minority Interest
37.40
0.00
37.40
Other related items
0.00
0.00
0.00
Consolidated Net Profit
326.27
295.62
30.65
10.37%
Equity Capital
25.37
169.41
-144.04
-85.02%
Face Value
1.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
12.86
17.45
-4.59
-26.30%
Diluted Earnings per share
12.86
17.45
-4.59
-26.30%
Operating Profit Margin (Excl OI)
22.29%
35.66%
0.00
-13.37%
Gross Profit Margin
23.14%
40.36%
0.00
-17.22%
PAT Margin
15.22%
28.39%
0.00
-13.17%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 2,392.50 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is -6.42% vs 10.73% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 6.55% vs 9.38% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 326.27 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is 15.47% vs 21.17% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 31.49% vs 37.95% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 533.35 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is -2.12% vs 30.86% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 15.17% vs 39.95% in Dec 2024

Quarterly - Interest
Interest 17.62 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is -10.15% vs 5.94% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 4.82% vs -49.67% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 22.29%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024